Effect of aldosterone synthase gene polymorphism 344C>T and risk of hypertensive disorders among Uzbek women

Πηγή: Nauchno-prakticheskii zhurnal «Medicinskaia genetika». :39-44

Θεματικοί όροι: 0301 basic medicine, preeclampsia, 0303 health sciences, 03 medical and health sciences, преэклампсия, альдостеронсинтаза, gestational hypertension, гестационная гипертензия, chronic arterial hypertension, aldosterone synthase, хроническая артериальная гипертензия, CYP11B2 gene, 3. Good health

Σύνδεσμος πρόσβασης: https://www.medgen-journal.ru/jour/article/download/624/400
https://www.medgen-journal.ru/jour/article/view/624
https://www.medgen-journal.ru/jour/article/download/624/400

Effect of aldosterone synthase gene CYP11B2 polymorphism 344C>T and risk of hypertensive disorders among Uzbek women ; Влияние полиморфизма-344C>T гена альдостеронсинтазыCYP11B2 на риск развития гипертензивных нарушений у беременных узбекской национальности

Συγγραφείς: U. A. Ashurova, D. K. Najmutdinova, K. Ya. Karimov, K. T. Boboev, У. А. Ашурова, Д. К. Наджмутдинова, Х. Я. Каримов, К. Т. Бобоев

Πηγή: Medical Genetics; Том 18, № 1 (2019); 39-44 ; Медицинская генетика; Том 18, № 1 (2019); 39-44 ; 2073-7998

Θεματικοί όροι: aldosterone synthase, альдостеронсинтаза, CYP11B2 gene, хроническая артериальная гипертензия, преэклампсия, gestational hypertension, chronic arterial hypertension, preeclampsia

Περιγραφή αρχείου: application/pdf

Relation: https://www.medgen-journal.ru/jour/article/view/624/400; Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. - 2005;308: 1592 -4.; Roberts J.M., Gammill H.S. Preeclampsia: recent insights. Hypertension. - 2005;46:1243 -9.; Salonen Ros H, Lichtenstein P, Lipworth L, Cnattingius S. Genetic effects on the liability of developing preeclampsia and gestational hypertension Am J MedGenet2000;91:256 - 60.; Krotz S, Fajardo J, Ghandi S, Patel A, Keith LG. Hypertensive disease in twin pregnancies: a review. Twin Res 2002;5:8 - 14 .; Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond) 2006;110:4 43 -58.; Escher G, Mohaupt M. Role of aldosterone availability in preeclampsia. Mol Aspects Med 2007;28:245 -54.; Shojaati K, Causevic M, Kadereit B, et al. Evidence for compromised aldosterone synthase enzyme activity in preeclampsia. Kidney Int 2004;66:2322 - 8.; Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, Mc Laughlin MK. Preeclampsia: an endothelial cell disorder. Am J ObstetGynecol1989;161:1200- 4.; SandrimVC, Palei AC, Metzger IF, Gomes VA, Cavalli RC, Tanus-Santos JE. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase -1 and soluble endogline in preeclampsia. Hypertension2008;52:402 -7.; Boduła A, Dołyk A, Protasiewicz J, et al. The role of the-344C/T polymorphism of the aldosterone synthase gene (CYP11B2) in cardiovascular diseases. Adv Hyg Exp Med 2007;61:838-47.; Clyne CD, Zhang Y, Slutsker L, et al. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol 1997;11:638-49.; Suzuki J, Otsuka F, Inagaki K, et al. Novel action of activing and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology 2004;145:639-49.; Connell JMC, Fraser R, MacKenzie SM, et al. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation. Mol Cell Endocrinol 2004;217:243-7.; Komiya I, Yamada T, Takara M, et al. Lys173Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 2000;35:699-703.; Poch E, Gonzales D, Giner V, Bragulat E, Coca A, Sierre A. Molecular basis of salt sensitivity in human hypertension: evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension2001;38:1204-9.; Mulatero P, Schiavone D, Fallo F, et al. CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension 2000;35:694-8.; Tsujita Y, Iwai N, Katsuya T, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita study. Hypertens Res 2001;24:105-9.; Tu Y, Cui G, Xu Y, Bao X, Wang X, Wang DW. Genetic polymorphism of CYP11B2 gene and stroke in the Han Chinese population and a meta-analysis. Pharmacogenet Genomics. 2011;21(3):115-20.; Rajan S, Ramu P, Umamaheswaran G, Adithan C. Association of aldosterone synthase (CYP11B2 C-344T) gene polymorphism & susceptibility to essential hypertension in a south Indian Tamil population. Indian J MedRes. 2010;132:379-85.; Vasconcelos D, Izidoro-Toledo TC, Palei Ana CT, Cavalli RC. Aldosterone synthase gene polymorphism is not associated with gestational hypertension or preeclampsia. ClinChimActa.2009;400:139 -141; Bogacz A, Bartkowiak-Wieczordz J, Procyk D, et al. Analysis of the gene polymorphism of aldosterone synthase (CYP11B2) and atrial natriuretic peptide (ANP) in women with preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2016;197:11-15

Διαθεσιμότητα: https://www.medgen-journal.ru/jour/article/view/624

Influence of С(-344)T variants of the aldosterone synthase CYP11B2 gene on serum aldosterone level and the risk of atrial fibrillation in patients with metabolic syndrome ; Влияние вариантов С(-344)T гена альдостеронсинтазы CYP11B2 на уровень альдостерона сыворотки крови и риск развития фибрилляции предсердий у пациентов с метаболическим синдромом

Συγγραφείς: S. N. Pchelina, A. S. Ulitina, I. . Ma, V. A. Ionin, A. A. Panteleeva, E. L. Zaslavskaya, E. A. Bazhenova, E. I. Baranova, С. Н. Пчелина, А. С. Улитина, И. . Ма, В. А. Ионин, А. А. Пантелеева, Е. Л. Заславская, Е. А. Баженова, Е. И. Баранова

Πηγή: Medical Genetics; Том 17, № 4 (2018); 31-36 ; Медицинская генетика; Том 17, № 4 (2018); 31-36 ; 2073-7998

Θεματικοί όροι: single nucleotide polymorphism, фибрилляция предсердий, альдостерон, альдостеронсинтаза, CYP11B2, однонуклеотидный полиморфизм, metabolic syndrome, atrial fibrillation, aldosterone, aldosterone synthase

Περιγραφή αρχείου: application/pdf

Relation: https://www.medgen-journal.ru/jour/article/view/430/307; Kirchhof P, Benussi S, Kotecha D et al. Рекомендации ESC по лечению пациентов с фибрилляцией предсердий, разработанные совместно с EACTS. Российский кардиологический журнал 2017; 7(147):7-86.; Munoz-Durango N, Vecchiola A, Gonzalez-Gomez LM et al. Modulation of immunity and inflammation by the mineralocorticoid receptor and aldosterone. Biomed Res Int. 2015;2015:652738.; Zhang XL, Wu LQ, Liu X et al. Association of angiotensin-converting enzyme gene I/D and CYP11B2 gene -344T/C polymorphisms with lone atrial fibrillation and its recurrence after catheter ablation. Exp Ther Med. 2012;4(4):741-747.; Fu X, Ma X, Zhong L, Song Z. Relationship between CYP11B2 -344T>C polymorphsim and atrial fibrillation: a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2015;16(1):185-8.; Lu WH, Bayike M, Liu JW et al. Association between aldosterone synthase (CYP11B2) -344C/T polymorphism and atrial fibrillation among Han and Kazak residents of the Xinjiang region. Int J Clin Exp Med. 2015;8(4):5513-9.; Ионин ВА, Соболева АВ, Листопад ОВ и др. Галектин 3 и альдостерон у пациентов с фибрилляцией предсердий и метаболическим синдромом. Российский кардиологический журнал 2015;120(4):79-83.; Rajan S, Ramu P, Umamaheswaran G, Adithan C. Association of aldosterone synthase (CYP11B2 C-344T) gene polymorphism & susceptibility to essential hypertension in a south Indian Tamil population. Indian J Med Res. 2010;132:379-85.; Bellili NM, Foucan L, Fumeron F et al. Associations of the -344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population. Am J Hypertens. 2010;23(6):660-7.; Kim YR, Kim SH, Kang SH et al. Association of CYP11B2 polymorphisms with metabolic syndrome patients. Biomed Rep. 2014;2(5):749-754.; Huang H, Darbar D. Genetic heterogeneity of atrial fibrillation susceptibility loci across racial or ethnic groups. Eur Heart J. 2017;38(34):2595-2598.; Кускаева АВ, Никулина СЮ, Чернова АА, Аксютина НВ. Генетические предикторы фибрилляции предсердий. Рациональная фармакотерапия в кардиологии 2016;12(3):331-336.; Christophersen IE, Ellinor PT. Genetics of atrial fibrillation: from families to genomes. J Hum Genet. 2016;61(1):61-70.; Christophersen IE, Rienstra M, Roselli C et al. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet. 2017;49(6):946-952.; Pereira PF, Priore SE, Bressan J. Aldosterone: a cardiometabolic risk hormone? Nutr Hosp. 2014;30:1191-1202.; Ingelsson E, Pencina MJ, Tofler GH et al. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation. 2007;116:984-992.; Bassett MH, Zhang Y, Clyne C et al. Differential regulation of aldosterone synthase and 11beta-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol. 2002;28(2):125-35.; White PC, Rainey WE. Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. J Clin Endocrinol Metab. 2005;90(2):1252-5.

Διαθεσιμότητα: https://www.medgen-journal.ru/jour/article/view/430
https://doi.org/10.25557/2073-7998.2018.04.31-36

Ассоциация полиморфизма - С/344Т гена альдостеронсинтазы (CYP11B2) с гипертрофией левого желудочка и уровнем альдостеронсинтазы плазмы у пациентов с неклапанной фибрилляцией предсердий

Συγγραφείς: Яцкевич, Е. С., Снежицкий, В. А.

Όροι ευρετηρίου: Сердца желудочка левого гипертрофия, Предсердий фибрилляция, Альдостеронсинтаза, Article

Σύνδεσμος: http://rep.bsmu.by/handle/BSMU/6265